×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [pediatric exclusivity]
Patent Term Extension Strategies in the Pharmaceutical Industry
34 views
Drug development and regulation
1.809 views
Health Care lecture - Changing Your Child's Future
188 views
Global Anxiety Disorders Market 2015-2019
156 views
1 One Year Post Exclusivity Adverse Event Review ADDERALL XR ® Pediatric Advisory Committee Meeting March 22, 2006 Susan K. McCune, M.D. Medical Officer
213 views
1 One Year Post Exclusivity Adverse Event Review: Topotecan Pediatric Subcommittee of the Anti-infective Drugs Advisory Committee Meeting June 9, 2004
214 views
Direct-to-Consumer Advertising: A Dangerous Game of Pitching Products to Parents Lynne Wells Graziano Department of History Case Western Reserve University
213 views
A New Pathway for Follow-on Biologics Presented by: Steve Nash
[email protected]
May 7, 2010
214 views
© 2009 Pharmaceutical Law Group PC Market Exclusivity Paradigm Gregory J. Glover, MD, JD Pharmaceutical Law Group
[email protected]
214 views
1 One Year Post-Exclusivity Adverse Event Review for Tamiflu® (oseltamivir) Pediatric Advisory Committee Meeting November 18, 2005 Melissa M. Truffa, R.Ph
216 views
1 One Year Post Exclusivity Adverse Event Review as Mandated by the Best Pharmaceuticals for Children Act Presented at the Psychopharmacologic Drugs Advisory
215 views